Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6061141 | Sleep Medicine | 2013 | 5 Pages |
Abstract
Intravenous iron sucrose appears to be a relatively effective therapy for patients with childhood-onset RLS/PLMD and iron deficiency who do not tolerate or respond to oral iron supplements. Side effects were transient. The most common adverse events were difficulty with intravenous line placement and GI disturbance. There is a need for systematic prospective studies on the safety and efficacy of intravenous iron sucrose in RLS/PLMD in children.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Kendra Grim, Bernard Lee, Alan Y. Sung, Suresh Kotagal,